Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Barry Uretsky

Concepts (599)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Percutaneous Coronary Intervention
97
2024
297
23.420
 Why?
Coronary Occlusion
58
2023
78
13.560
 Why?
Coronary Artery Disease
40
2024
274
13.310
 Why?
Fractional Flow Reserve, Myocardial
39
2023
126
12.120
 Why?
Angioplasty, Balloon, Coronary
48
2020
130
11.210
 Why?
Stents
50
2023
338
8.810
 Why?
Coronary Angiography
95
2023
334
8.500
 Why?
Coronary Vessels
32
2024
152
7.990
 Why?
Coronary Stenosis
22
2021
99
6.580
 Why?
Myocardial Infarction
46
2024
389
5.300
 Why?
Drug-Eluting Stents
22
2023
93
5.210
 Why?
Treatment Outcome
119
2024
5141
4.840
 Why?
Cardiac Catheterization
19
2023
201
4.180
 Why?
Coronary Artery Bypass
17
2022
118
3.080
 Why?
Acute Coronary Syndrome
8
2022
78
3.020
 Why?
Humans
222
2024
49974
2.760
 Why?
Chronic Disease
52
2023
567
2.510
 Why?
Tomography, Optical Coherence
8
2018
100
2.460
 Why?
Saphenous Vein
12
2021
61
2.270
 Why?
Graft Occlusion, Vascular
13
2021
73
2.240
 Why?
Platelet Aggregation Inhibitors
11
2014
172
2.180
 Why?
Risk Factors
63
2023
3613
2.170
 Why?
Coronary Thrombosis
8
2020
23
2.050
 Why?
Registries
32
2023
522
1.890
 Why?
Myocardial Ischemia
11
2020
120
1.860
 Why?
Male
116
2024
25241
1.830
 Why?
Cardiology
13
2019
89
1.800
 Why?
Coronary Restenosis
8
2021
31
1.780
 Why?
Thrombosis
11
2018
248
1.770
 Why?
Predictive Value of Tests
22
2023
903
1.770
 Why?
Myocardium
17
2013
436
1.690
 Why?
Aged
68
2023
9310
1.640
 Why?
Heptanoic Acids
15
2008
34
1.620
 Why?
Pyrroles
15
2008
69
1.570
 Why?
Time Factors
39
2023
2903
1.550
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
13
2022
138
1.500
 Why?
Middle Aged
75
2024
12069
1.450
 Why?
Heart Injuries
3
2019
15
1.430
 Why?
Risk Assessment
26
2023
1259
1.420
 Why?
Myocardial Reperfusion Injury
10
2011
48
1.290
 Why?
Cardiac Tamponade
2
2024
26
1.230
 Why?
Collateral Circulation
10
2020
39
1.200
 Why?
Female
77
2024
26472
1.190
 Why?
Vasodilator Agents
5
2016
96
1.100
 Why?
Coronary Circulation
9
2024
57
1.080
 Why?
Heart-Assist Devices
3
2020
148
1.070
 Why?
Prosthesis Design
11
2021
237
1.010
 Why?
Contrast Media
8
2018
184
1.010
 Why?
Cardiac Catheters
4
2020
12
1.010
 Why?
Societies, Medical
9
2019
175
1.010
 Why?
Thrombolytic Therapy
2
2020
110
0.990
 Why?
Ventricular Dysfunction, Left
6
2018
91
0.980
 Why?
Heart Failure
11
2019
458
0.980
 Why?
Pericarditis
2
2022
20
0.960
 Why?
Ventricular Function, Left
11
2023
154
0.930
 Why?
Adenosine
7
2018
69
0.930
 Why?
Balloon Occlusion
1
2024
18
0.920
 Why?
Pericardial Effusion
1
2024
43
0.900
 Why?
Hemorrhage
4
2019
197
0.900
 Why?
Cardiovascular Agents
5
2009
54
0.880
 Why?
Coronary Disease
5
2015
131
0.870
 Why?
Occupational Health
1
2023
68
0.850
 Why?
Postoperative Complications
9
2019
984
0.850
 Why?
Aneurysm, False
5
2020
44
0.850
 Why?
Pericarditis, Constrictive
1
2022
3
0.850
 Why?
Aorta
3
2019
161
0.810
 Why?
Hypotension, Controlled
1
2021
3
0.800
 Why?
Radiography, Interventional
7
2018
60
0.790
 Why?
Retrospective Studies
27
2020
6108
0.790
 Why?
Anemia
1
2022
68
0.790
 Why?
Thrombocytopenia
1
2022
85
0.760
 Why?
Mammary Arteries
3
2017
8
0.760
 Why?
Absorbable Implants
2
2022
16
0.760
 Why?
Inferior Wall Myocardial Infarction
1
2020
1
0.740
 Why?
Time-to-Treatment
2
2020
61
0.730
 Why?
Thiazolidinediones
6
2008
82
0.720
 Why?
Shock, Cardiogenic
1
2020
25
0.710
 Why?
Algorithms
4
2021
615
0.710
 Why?
Prognosis
16
2023
1942
0.710
 Why?
Cardiovascular Diseases
11
2015
440
0.700
 Why?
Digitalis
1
2019
4
0.690
 Why?
Diabetic Angiopathies
2
2013
18
0.690
 Why?
Enbucrilate
1
2019
6
0.680
 Why?
Tissue Adhesives
1
2019
13
0.680
 Why?
Arterial Pressure
1
2019
43
0.680
 Why?
Hyperemia
3
2016
19
0.680
 Why?
Pericardium
4
2022
29
0.670
 Why?
Operative Time
3
2019
73
0.660
 Why?
Guideline Adherence
1
2020
133
0.660
 Why?
Practice Guidelines as Topic
2
2020
449
0.640
 Why?
Aspirin
5
2022
114
0.630
 Why?
Hematoma
2
2013
64
0.630
 Why?
Hydrostatic Pressure
1
2017
8
0.600
 Why?
Follow-Up Studies
16
2019
2182
0.600
 Why?
Angioplasty, Balloon
4
2022
65
0.590
 Why?
Perioperative Care
5
2015
41
0.590
 Why?
Death, Sudden, Cardiac
2
2008
53
0.590
 Why?
Heart Septum
2
2010
22
0.590
 Why?
Creatine Kinase, MB Form
3
2013
6
0.590
 Why?
Adrenergic beta-Antagonists
3
2008
102
0.580
 Why?
Surgical Procedures, Operative
4
2015
63
0.570
 Why?
Foramen Ovale, Patent
2
2014
27
0.570
 Why?
Purinergic P2Y Receptor Antagonists
2
2014
29
0.550
 Why?
Heart Ventricles
4
2012
249
0.540
 Why?
Veterans
1
2022
555
0.530
 Why?
Severity of Illness Index
13
2019
945
0.530
 Why?
Propranolol
2
2008
78
0.520
 Why?
Alloys
2
2020
9
0.520
 Why?
Prospective Studies
14
2023
2364
0.520
 Why?
United States
24
2022
4860
0.520
 Why?
Electrocardiography
9
2022
257
0.510
 Why?
Aortic Valve
3
2022
113
0.500
 Why?
Fibrinolytic Agents
3
2014
124
0.490
 Why?
Vascular System Injuries
1
2015
36
0.490
 Why?
Tomography, X-Ray Computed
5
2013
1159
0.490
 Why?
Wounds, Penetrating
1
2015
41
0.490
 Why?
Randomized Controlled Trials as Topic
9
2015
549
0.480
 Why?
Stroke Volume
7
2023
116
0.480
 Why?
Ultrasonography, Interventional
7
2013
136
0.480
 Why?
Cardiotonic Agents
7
2019
66
0.470
 Why?
Purines
2
2014
38
0.470
 Why?
Adenosine A2 Receptor Agonists
1
2014
5
0.470
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
3
2009
32
0.470
 Why?
Physician-Patient Relations
1
2015
140
0.460
 Why?
Anterior Wall Myocardial Infarction
2
2012
7
0.460
 Why?
Computer-Assisted Instruction
1
2014
30
0.460
 Why?
Metals
2
2011
34
0.460
 Why?
Cyclooxygenase 2
8
2008
45
0.460
 Why?
Piperazines
2
2012
117
0.450
 Why?
Blood Vessel Prosthesis Implantation
4
2009
120
0.450
 Why?
Pyrazoles
2
2014
113
0.450
 Why?
Anticholesteremic Agents
3
2008
28
0.450
 Why?
Troponin T
2
2011
12
0.450
 Why?
Mentors
1
2014
55
0.450
 Why?
Atrial Function, Left
1
2013
3
0.440
 Why?
Arteries
1
2013
93
0.440
 Why?
Incidence
12
2018
1003
0.440
 Why?
Endarterectomy, Carotid
2
2011
62
0.440
 Why?
Lipoxins
3
2008
3
0.440
 Why?
Cardiac Surgical Procedures
3
2014
297
0.430
 Why?
Tissue Donors
1
2013
111
0.430
 Why?
Drug Eruptions
1
2012
13
0.420
 Why?
Rats, Sprague-Dawley
14
2008
1597
0.410
 Why?
Thiophenes
1
2012
36
0.410
 Why?
Physicians
2
2015
233
0.410
 Why?
Rats
19
2011
3305
0.410
 Why?
Stroke
3
2013
492
0.400
 Why?
Drug Administration Schedule
5
2014
376
0.400
 Why?
Embolism
2
2013
20
0.400
 Why?
Cyclooxygenase Inhibitors
5
2007
39
0.400
 Why?
Quality Assurance, Health Care
4
2012
149
0.400
 Why?
Diverticulum
1
2011
22
0.390
 Why?
Internet
1
2014
259
0.390
 Why?
Troponin I
1
2011
18
0.380
 Why?
Transurethral Resection of Prostate
1
2011
10
0.380
 Why?
Intraoperative Complications
4
2020
112
0.380
 Why?
Carotid Arteries
1
2011
85
0.380
 Why?
Pressure
3
2017
105
0.380
 Why?
Clinical Trials as Topic
4
2012
461
0.380
 Why?
Receptors, Adrenergic, beta-2
2
2009
16
0.380
 Why?
Myocytes, Cardiac
5
2011
125
0.380
 Why?
Embolic Protection Devices
1
2010
6
0.370
 Why?
Paclitaxel
1
2011
84
0.370
 Why?
Receptors, Opioid, delta
2
2009
26
0.370
 Why?
Clinical Competence
4
2013
393
0.370
 Why?
Heart
5
2006
326
0.360
 Why?
Pericardiectomy
2
2024
6
0.360
 Why?
Mitral Valve
1
2010
49
0.360
 Why?
Endocarditis
1
2010
32
0.360
 Why?
Kaplan-Meier Estimate
6
2017
466
0.350
 Why?
Anticoagulants
5
2024
250
0.330
 Why?
Sirolimus
2
2009
62
0.330
 Why?
Echocardiography, Transesophageal
2
2006
60
0.330
 Why?
Hypoglycemic Agents
3
2006
168
0.330
 Why?
Carotid Artery, Common
2
2006
44
0.320
 Why?
Myocardial Bridging
1
2008
2
0.320
 Why?
Heart Failure, Systolic
1
2008
7
0.320
 Why?
Tissue Plasminogen Activator
1
2009
109
0.320
 Why?
Peptides
2
2008
223
0.310
 Why?
Suction
1
2008
23
0.310
 Why?
Aortic Valve Stenosis
2
2022
60
0.310
 Why?
Azetidines
1
2008
6
0.310
 Why?
Heart Valve Prosthesis
2
2022
75
0.310
 Why?
Consensus
2
2007
148
0.310
 Why?
Patient Selection
7
2012
253
0.310
 Why?
Telemedicine
1
2014
448
0.300
 Why?
Heart Septal Defects, Atrial
2
2013
44
0.300
 Why?
Vascular Patency
5
2020
82
0.290
 Why?
Laboratories, Hospital
1
2006
6
0.280
 Why?
Coronary Aneurysm
1
2007
17
0.280
 Why?
Terminology as Topic
3
2013
62
0.280
 Why?
Defibrillators, Implantable
2
2007
60
0.280
 Why?
Echocardiography, Three-Dimensional
1
2006
12
0.280
 Why?
Pacemaker, Artificial
1
2007
34
0.280
 Why?
Animals
25
2022
13187
0.270
 Why?
Chi-Square Distribution
3
2017
280
0.270
 Why?
Mitral Valve Insufficiency
2
2007
44
0.270
 Why?
Hemodynamics
6
2018
228
0.270
 Why?
Angina, Unstable
3
2016
17
0.270
 Why?
Bacteremia
1
2007
90
0.260
 Why?
Inpatients
2
2018
190
0.260
 Why?
Gadolinium DTPA
1
2005
25
0.260
 Why?
Kidney Failure, Chronic
2
2004
198
0.260
 Why?
Lipopolysaccharides
1
2006
192
0.260
 Why?
Nitric Oxide Synthase Type III
6
2008
78
0.260
 Why?
Carotid Artery Diseases
1
2005
33
0.250
 Why?
Angina, Stable
2
2016
7
0.250
 Why?
Neovascularization, Physiologic
2
2005
68
0.250
 Why?
Prostaglandins
1
2005
20
0.250
 Why?
Calcium
1
2007
396
0.250
 Why?
Pain Management
3
2015
160
0.250
 Why?
Program Evaluation
1
2006
354
0.250
 Why?
Renal Insufficiency
1
2005
109
0.240
 Why?
Chemokine CCL2
1
2004
70
0.240
 Why?
Plasminogen Activator Inhibitor 1
1
2004
6
0.240
 Why?
Europe
6
2019
74
0.240
 Why?
History, 21st Century
2
2019
56
0.240
 Why?
Pericardiocentesis
1
2024
16
0.240
 Why?
Monocytes
1
2004
131
0.230
 Why?
Equipment Design
3
2020
284
0.230
 Why?
History, 20th Century
2
2019
99
0.230
 Why?
Secondary Prevention
2
2015
78
0.230
 Why?
Proportional Hazards Models
4
2017
402
0.230
 Why?
Reoperation
5
2013
454
0.230
 Why?
Staphylococcal Infections
1
2007
268
0.230
 Why?
Heart Rupture, Post-Infarction
1
2003
2
0.230
 Why?
Reproducibility of Results
6
2016
1193
0.230
 Why?
Cardiomyopathy, Hypertrophic
1
2004
31
0.230
 Why?
Nitric Oxide Synthase Type II
4
2008
66
0.220
 Why?
Digoxin
2
2019
21
0.220
 Why?
Double-Blind Method
5
2020
681
0.220
 Why?
Disease Models, Animal
9
2011
1455
0.220
 Why?
Calcinosis
1
2023
49
0.220
 Why?
Materials Testing
2
2020
58
0.210
 Why?
American Heart Association
4
2015
32
0.210
 Why?
Hospital Mortality
5
2019
409
0.210
 Why?
Dose-Response Relationship, Drug
8
2017
1376
0.210
 Why?
Adult
11
2019
13236
0.210
 Why?
Femoral Artery
2
2019
100
0.200
 Why?
Coronary Vessel Anomalies
2
2017
37
0.200
 Why?
Recurrence
6
2016
652
0.190
 Why?
Angiography
3
2012
126
0.190
 Why?
Retreatment
2
2012
57
0.190
 Why?
Drug Therapy, Combination
5
2008
377
0.190
 Why?
Heart Valve Prosthesis Implantation
2
2016
80
0.190
 Why?
Vasodilation
1
2021
96
0.190
 Why?
Up-Regulation
4
2011
452
0.180
 Why?
United States Department of Veterans Affairs
1
2022
285
0.180
 Why?
Ischemia
1
2021
153
0.180
 Why?
Angioplasty
1
2020
20
0.180
 Why?
Calcitonin Gene-Related Peptide
2
2009
22
0.170
 Why?
Plaque, Atherosclerotic
1
2019
38
0.170
 Why?
6-Ketoprostaglandin F1 alpha
3
2008
6
0.170
 Why?
Logistic Models
3
2018
888
0.170
 Why?
Specialization
1
2019
46
0.170
 Why?
Atherectomy
1
2019
13
0.170
 Why?
Russia
4
2019
10
0.160
 Why?
Quality Improvement
2
2011
208
0.160
 Why?
Cost-Benefit Analysis
2
2014
274
0.160
 Why?
Propanolamines
2
2011
14
0.160
 Why?
Radial Artery
1
2019
29
0.160
 Why?
Catheterization
1
2019
96
0.160
 Why?
Peripheral Arterial Disease
1
2019
66
0.160
 Why?
Proto-Oncogene Proteins c-akt
3
2009
157
0.160
 Why?
Catheterization, Peripheral
1
2019
46
0.160
 Why?
Odds Ratio
3
2016
545
0.160
 Why?
Patient Care Planning
1
2019
67
0.160
 Why?
Aged, 80 and over
5
2017
3129
0.160
 Why?
Feasibility Studies
1
2020
375
0.160
 Why?
Emergency Medical Services
1
2019
109
0.150
 Why?
Diabetes Mellitus, Type 2
1
2004
477
0.150
 Why?
Medicare
2
2011
246
0.150
 Why?
Patient Safety
1
2018
102
0.150
 Why?
Education, Medical
1
2019
112
0.150
 Why?
Constriction, Pathologic
1
2017
94
0.150
 Why?
Adventitia
1
2017
4
0.150
 Why?
Education, Medical, Graduate
3
2013
205
0.150
 Why?
Hospitalization
3
2011
652
0.140
 Why?
Curriculum
3
2013
401
0.140
 Why?
Cardiac Pacing, Artificial
2
2008
28
0.140
 Why?
Risk
2
2011
320
0.140
 Why?
Prevalence
4
2018
944
0.140
 Why?
Advisory Committees
2
2014
63
0.140
 Why?
Survival Analysis
3
2010
653
0.140
 Why?
Nitric Oxide Synthase
2
2008
75
0.140
 Why?
Phosphorylation
6
2008
535
0.140
 Why?
Propensity Score
1
2017
123
0.140
 Why?
Simvastatin
2
2008
29
0.130
 Why?
Aortic Valve Insufficiency
1
2016
21
0.130
 Why?
Administration, Oral
5
2015
426
0.130
 Why?
Benzazepines
2
2006
19
0.130
 Why?
Renal Insufficiency, Chronic
1
2018
169
0.130
 Why?
Postpericardiotomy Syndrome
1
2015
4
0.130
 Why?
Diagnostic Techniques, Cardiovascular
2
2012
4
0.130
 Why?
Magnetic Resonance Imaging
1
2022
1537
0.130
 Why?
Angina Pectoris
2
2020
18
0.120
 Why?
Colchicine
1
2015
28
0.120
 Why?
Smad3 Protein
1
2014
10
0.120
 Why?
Th2 Cells
1
2014
21
0.120
 Why?
Cholesterol, Dietary
1
2014
19
0.120
 Why?
Cyclic AMP-Dependent Protein Kinases
3
2011
51
0.120
 Why?
Patient Care Management
1
2014
18
0.120
 Why?
Venous Thrombosis
1
2015
90
0.120
 Why?
Area Under Curve
3
2022
182
0.120
 Why?
Receptors, LDL
1
2014
66
0.120
 Why?
Cardiovascular System
1
2014
49
0.120
 Why?
Atherosclerosis
2
2014
214
0.120
 Why?
Thromboembolism
1
2014
54
0.120
 Why?
Dependovirus
1
2014
101
0.110
 Why?
Remote Consultation
1
2014
29
0.110
 Why?
Transfection
1
2014
354
0.110
 Why?
Drug Costs
1
2014
39
0.110
 Why?
Quality Indicators, Health Care
2
2011
86
0.110
 Why?
Arrhythmias, Cardiac
2
2012
95
0.110
 Why?
Septal Occluder Device
1
2013
31
0.110
 Why?
Echocardiography, Doppler, Color
1
2013
23
0.110
 Why?
Pulmonary Edema
1
2013
18
0.110
 Why?
Echocardiography, Doppler
2
2016
53
0.110
 Why?
Cohort Studies
5
2022
1422
0.110
 Why?
General Surgery
1
2014
105
0.110
 Why?
Signal Transduction
3
2009
1618
0.110
 Why?
Evidence-Based Medicine
2
2011
247
0.110
 Why?
Heparin
2
2024
92
0.110
 Why?
Pleural Effusion
1
2013
38
0.110
 Why?
Case-Control Studies
2
2013
1131
0.110
 Why?
Kidney Diseases
2
2007
214
0.100
 Why?
Image Processing, Computer-Assisted
1
2014
242
0.100
 Why?
Myocardial Revascularization
2
2012
13
0.100
 Why?
Embolism, Cholesterol
1
2011
2
0.100
 Why?
Hypertrophy, Left Ventricular
2
2009
39
0.100
 Why?
Age Factors
3
2021
1087
0.100
 Why?
Cardiovascular Surgical Procedures
2
2012
10
0.100
 Why?
Ultrasonography
2
2010
436
0.100
 Why?
Milrinone
1
2011
9
0.100
 Why?
Treatment Failure
2
2018
114
0.100
 Why?
Insurance Claim Review
1
2011
36
0.100
 Why?
Enkephalin, D-Penicillamine (2,5)-
2
2009
3
0.090
 Why?
Unnecessary Procedures
1
2011
21
0.090
 Why?
Equipment Failure
2
2008
62
0.090
 Why?
Punctures
2
2019
46
0.090
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2011
65
0.090
 Why?
Multivariate Analysis
3
2016
577
0.090
 Why?
Thrombectomy
1
2011
67
0.090
 Why?
Cyclooxygenase 2 Inhibitors
2
2007
19
0.090
 Why?
Injections, Intra-Arterial
2
2015
13
0.090
 Why?
Necrosis
1
2010
176
0.090
 Why?
Surgical Instruments
1
2010
28
0.090
 Why?
Magnetic Resonance Imaging, Cine
1
2010
56
0.090
 Why?
Disease Management
3
2014
174
0.090
 Why?
Systole
1
2010
68
0.090
 Why?
Reperfusion Injury
2
2007
87
0.090
 Why?
Receptors, Calcitonin Gene-Related Peptide
1
2009
4
0.090
 Why?
Phosphodiesterase Inhibitors
2
2007
23
0.090
 Why?
Myocardial Contraction
2
2009
105
0.080
 Why?
Cells, Cultured
3
2009
1573
0.080
 Why?
ROC Curve
2
2022
232
0.080
 Why?
Hyperlipidemias
2
2011
49
0.080
 Why?
Endothelium, Vascular
2
2007
252
0.080
 Why?
Drug Administration Routes
1
2008
10
0.080
 Why?
Leukotriene B4
1
2008
1
0.080
 Why?
Arachidonate 5-Lipoxygenase
1
2008
4
0.080
 Why?
Survival Rate
3
2018
894
0.080
 Why?
Hemostasis, Surgical
1
2008
12
0.080
 Why?
Fatal Outcome
2
2007
195
0.080
 Why?
Phospholipases A
2
2006
13
0.080
 Why?
Phospholipases A2
2
2006
14
0.080
 Why?
Patient Transfer
1
2009
94
0.080
 Why?
Comorbidity
1
2010
615
0.080
 Why?
Diabetes Complications
2
2011
118
0.080
 Why?
Meta-Analysis as Topic
1
2008
39
0.080
 Why?
Drainage
1
2008
78
0.080
 Why?
Sulfonamides
2
2008
129
0.080
 Why?
Myocardial Reperfusion
1
2007
8
0.070
 Why?
Mitogen-Activated Protein Kinase 3
1
2007
50
0.070
 Why?
Tetrazoles
1
2007
41
0.070
 Why?
Dipyridamole
1
2007
9
0.070
 Why?
Combined Modality Therapy
1
2009
637
0.070
 Why?
Prosthesis Failure
2
2012
107
0.070
 Why?
Microinjections
2
2018
29
0.070
 Why?
Waiting Lists
1
2007
49
0.070
 Why?
Prostaglandin D2
1
2007
21
0.070
 Why?
Cyclooxygenase 1
1
2007
5
0.070
 Why?
Sex Factors
2
2022
691
0.070
 Why?
Thoracic Surgery
1
2007
16
0.070
 Why?
Patient Admission
1
2007
77
0.070
 Why?
Nitroso Compounds
1
2006
4
0.070
 Why?
Analysis of Variance
1
2008
562
0.070
 Why?
Calcium Signaling
1
2007
56
0.070
 Why?
Enzyme Induction
1
2006
80
0.070
 Why?
Cardiac Output, Low
1
2006
7
0.070
 Why?
Biotin
1
2006
45
0.070
 Why?
PPAR gamma
1
2007
73
0.070
 Why?
Chest Pain
1
2006
53
0.070
 Why?
Ubiquinone
1
2006
12
0.070
 Why?
NF-kappa B
1
2008
314
0.070
 Why?
Drug Interactions
1
2007
206
0.070
 Why?
Acute Disease
3
2019
366
0.070
 Why?
Hemofiltration
1
2006
7
0.070
 Why?
Magnesium
1
2006
35
0.070
 Why?
Heart Atria
1
2006
55
0.070
 Why?
Electric Countershock
1
2006
30
0.070
 Why?
Preoperative Care
1
2007
164
0.070
 Why?
Intracranial Embolism
1
2006
27
0.070
 Why?
Forecasting
1
2007
150
0.070
 Why?
Diagnosis, Differential
2
2012
1037
0.070
 Why?
Ischemic Preconditioning
1
2005
4
0.070
 Why?
Radiology
1
2008
131
0.070
 Why?
Texas
2
2006
137
0.070
 Why?
Aortic Rupture
1
2006
19
0.070
 Why?
Triiodobenzoic Acids
1
2005
9
0.070
 Why?
Partnership Practice
1
2005
1
0.070
 Why?
Myocardial Stunning
1
2005
1
0.070
 Why?
Organizational Affiliation
1
2005
2
0.070
 Why?
Health Planning
1
2005
13
0.070
 Why?
Carbazoles
1
2005
16
0.070
 Why?
Heart Transplantation
1
2009
312
0.070
 Why?
Gastrointestinal Hemorrhage
1
2006
78
0.060
 Why?
Metoprolol
1
2005
13
0.060
 Why?
Foreign Bodies
1
2006
65
0.060
 Why?
Device Removal
1
2006
85
0.060
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2006
121
0.060
 Why?
Disease Progression
1
2008
825
0.060
 Why?
Aortic Coarctation
1
2006
31
0.060
 Why?
Accidents, Traffic
1
2006
88
0.060
 Why?
Arginine Vasopressin
1
2005
8
0.060
 Why?
Isoxazoles
1
2005
14
0.060
 Why?
Intramolecular Oxidoreductases
1
2005
14
0.060
 Why?
Prostaglandin-Endoperoxide Synthases
1
2005
26
0.060
 Why?
Education, Medical, Continuing
1
2005
68
0.060
 Why?
Pyrrolidines
1
2006
83
0.060
 Why?
Ephedrine
1
2004
21
0.060
 Why?
Tetralogy of Fallot
1
2006
86
0.060
 Why?
Regional Blood Flow
1
2004
108
0.060
 Why?
Hyperhomocysteinemia
1
2004
29
0.060
 Why?
Leadership
1
2005
101
0.060
 Why?
Polyethylene Terephthalates
1
2004
10
0.060
 Why?
Brachiocephalic Trunk
1
2004
6
0.060
 Why?
Membrane Proteins
1
2007
341
0.060
 Why?
Ventricular Remodeling
1
2004
54
0.060
 Why?
Creatinine
1
2004
139
0.060
 Why?
Pregnancy Complications, Cardiovascular
1
2004
35
0.060
 Why?
Antioxidants
1
2006
249
0.060
 Why?
Arteriosclerosis
1
2004
54
0.060
 Why?
Swine Diseases
1
2004
7
0.060
 Why?
Random Allocation
1
2005
281
0.060
 Why?
Abnormalities, Multiple
1
2006
167
0.060
 Why?
Vascular Endothelial Growth Factor A
1
2005
201
0.060
 Why?
Inflammation
2
2007
604
0.060
 Why?
Potassium Channels
1
2004
31
0.060
 Why?
Enoxaparin
1
2024
27
0.060
 Why?
ATP-Binding Cassette Transporters
1
2004
34
0.060
 Why?
Hypertension
2
2011
533
0.060
 Why?
Atrial Fibrillation
1
2006
180
0.060
 Why?
Heart Diseases
1
2006
206
0.060
 Why?
Cytochrome P-450 Enzyme System
1
2005
195
0.060
 Why?
Glomerular Filtration Rate
2
2018
111
0.060
 Why?
Vasoconstrictor Agents
1
2004
84
0.060
 Why?
Creatine Kinase
1
2003
28
0.060
 Why?
Staphylococcus aureus
1
2007
326
0.060
 Why?
Sample Size
1
2003
37
0.060
 Why?
Isoenzymes
1
2003
168
0.050
 Why?
Retroperitoneal Space
1
2002
30
0.050
 Why?
Death
1
2022
20
0.050
 Why?
C-Reactive Protein
1
2003
142
0.050
 Why?
Quality of Life
1
2008
836
0.050
 Why?
Internship and Residency
1
2008
443
0.050
 Why?
Cardiomyopathies
1
2003
108
0.050
 Why?
Drug Synergism
3
2007
150
0.050
 Why?
Immunohistochemistry
1
2005
973
0.050
 Why?
Renal Dialysis
1
2003
169
0.050
 Why?
Morphine Derivatives
1
2022
29
0.050
 Why?
Anesthesia
1
2002
73
0.050
 Why?
Mass Screening
1
2004
353
0.050
 Why?
Hospitals
1
2022
175
0.050
 Why?
Kidney
1
2005
665
0.050
 Why?
Benchmarking
2
2011
61
0.050
 Why?
Heart Arrest
1
2002
149
0.050
 Why?
Tissue Scaffolds
1
2020
33
0.050
 Why?
Arkansas
2
2016
1977
0.040
 Why?
Biocompatible Materials
1
2020
69
0.040
 Why?
Public Policy
2
2012
38
0.040
 Why?
Oxidative Stress
1
2004
770
0.040
 Why?
Anti-Inflammatory Agents
2
2015
161
0.040
 Why?
Risk Adjustment
1
2019
16
0.040
 Why?
Mice, Knockout
2
2014
841
0.040
 Why?
Injections, Intralesional
1
2018
31
0.040
 Why?
Internationality
1
2018
36
0.040
 Why?
Radiation Dosage
1
2019
157
0.040
 Why?
Administration, Intravenous
1
2018
69
0.040
 Why?
Immunoblotting
2
2008
118
0.040
 Why?
Radiation Monitoring
1
2017
7
0.040
 Why?
International Cooperation
2
2007
44
0.040
 Why?
Enzyme-Linked Immunosorbent Assay
2
2008
244
0.040
 Why?
Italy
1
2015
26
0.030
 Why?
Mice
3
2014
5739
0.030
 Why?
Blood Flow Velocity
1
2015
101
0.030
 Why?
Phlebography
1
2015
61
0.030
 Why?
Tubulin Modulators
1
2015
31
0.030
 Why?
Cross-Sectional Studies
1
2020
1557
0.030
 Why?
Cause of Death
2
2007
143
0.030
 Why?
Syndrome
2
2006
237
0.030
 Why?
Time
1
2014
25
0.030
 Why?
Journal Impact Factor
1
2014
7
0.030
 Why?
Models, Cardiovascular
2
2004
21
0.030
 Why?
Genetic Vectors
1
2014
125
0.030
 Why?
Fibrosis
1
2014
179
0.030
 Why?
Monitoring, Physiologic
1
2014
120
0.030
 Why?
Learning Curve
1
2013
18
0.030
 Why?
Ischemic Attack, Transient
1
2013
56
0.030
 Why?
Apoptosis
2
2011
1101
0.030
 Why?
Cardiac Imaging Techniques
1
2012
8
0.030
 Why?
Gene Expression Regulation
2
2008
976
0.030
 Why?
Mice, Inbred C57BL
2
2008
1816
0.030
 Why?
Tissue Survival
1
2012
10
0.030
 Why?
Myocardial Perfusion Imaging
1
2012
16
0.030
 Why?
Exercise Test
2
2002
121
0.020
 Why?
Phosphodiesterase 3 Inhibitors
1
2011
1
0.020
 Why?
Tomography, Emission-Computed, Single-Photon
1
2012
52
0.020
 Why?
Adrenergic beta-1 Receptor Antagonists
1
2011
6
0.020
 Why?
Health Policy
1
2012
153
0.020
 Why?
In Situ Nick-End Labeling
1
2011
57
0.020
 Why?
Echocardiography
2
2005
378
0.020
 Why?
Recovery of Function
1
2012
188
0.020
 Why?
Diagnostic Imaging
1
2012
176
0.020
 Why?
Infusions, Intravenous
1
2011
206
0.020
 Why?
Critical Care
1
2012
213
0.020
 Why?
Program Development
1
2011
166
0.020
 Why?
Data Collection
1
2011
279
0.020
 Why?
Adrenergic beta-2 Receptor Antagonists
1
2009
1
0.020
 Why?
Adrenergic beta-2 Receptor Agonists
1
2009
2
0.020
 Why?
Transplantation, Homologous
1
2009
139
0.020
 Why?
Graft Rejection
1
2009
161
0.020
 Why?
Isoquinolines
1
2008
25
0.020
 Why?
Cell Death
1
2009
181
0.020
 Why?
Serine
1
2008
37
0.020
 Why?
Tyrphostins
1
2008
9
0.020
 Why?
Janus Kinases
1
2008
8
0.020
 Why?
Selection Bias
1
2008
16
0.020
 Why?
Electrophoretic Mobility Shift Assay
1
2008
73
0.020
 Why?
Ischemic Preconditioning, Myocardial
1
2007
2
0.020
 Why?
Organ Culture Techniques
1
2007
48
0.020
 Why?
Creatine Kinase, BB Form
1
2007
1
0.020
 Why?
Enzyme Activation
1
2008
276
0.020
 Why?
Receptors, Purinergic P1
1
2007
8
0.020
 Why?
Survival
1
2007
12
0.020
 Why?
Theophylline
1
2007
19
0.020
 Why?
Immunologic Factors
1
2008
114
0.020
 Why?
5'-Nucleotidase
1
2007
12
0.020
 Why?
Nitriles
1
2007
54
0.020
 Why?
Blood Coagulation
1
2007
56
0.020
 Why?
Butadienes
1
2007
48
0.020
 Why?
Models, Chemical
1
2007
66
0.020
 Why?
Premedication
1
2007
21
0.020
 Why?
Smoking
1
2011
511
0.020
 Why?
Drug Combinations
1
2007
123
0.020
 Why?
Coenzymes
1
2006
3
0.020
 Why?
Oncogene Protein v-akt
1
2006
10
0.020
 Why?
Fluid Therapy
1
2007
76
0.020
 Why?
Alanine
1
2006
42
0.020
 Why?
Phosphoric Monoester Hydrolases
1
2006
22
0.020
 Why?
Receptors, Vasopressin
1
2006
23
0.020
 Why?
Protein Kinase Inhibitors
1
2008
204
0.020
 Why?
Amidines
1
2006
8
0.020
 Why?
Benzylamines
1
2006
15
0.020
 Why?
Educational Measurement
1
2008
208
0.020
 Why?
Sulfones
1
2006
24
0.020
 Why?
PTEN Phosphohydrolase
1
2006
55
0.020
 Why?
Research Design
1
2008
344
0.020
 Why?
Models, Animal
1
2006
233
0.020
 Why?
Magnetic Resonance Angiography
1
2006
77
0.020
 Why?
Heart Conduction System
1
2005
24
0.020
 Why?
Nitric Oxide
1
2007
253
0.020
 Why?
Body Weight
1
2007
513
0.020
 Why?
Safety
1
2005
78
0.020
 Why?
Enzyme Inhibitors
1
2007
391
0.020
 Why?
Multicenter Studies as Topic
1
2005
84
0.020
 Why?
Nitroglycerin
1
2004
7
0.020
 Why?
Radiography
1
2006
489
0.020
 Why?
Injections, Intravenous
1
2004
140
0.010
 Why?
Aortography
1
2004
35
0.010
 Why?
Glyburide
1
2004
6
0.010
 Why?
Anastomosis, Surgical
1
2004
66
0.010
 Why?
Sensitivity and Specificity
1
2006
861
0.010
 Why?
Ventricular Fibrillation
1
2004
16
0.010
 Why?
Health Personnel
1
2007
246
0.010
 Why?
Anesthesia, Obstetrical
1
2004
39
0.010
 Why?
Models, Biological
1
2007
727
0.010
 Why?
Statistics as Topic
1
2004
88
0.010
 Why?
Vascular Surgical Procedures
1
2006
165
0.010
 Why?
Patient Discharge
1
2006
320
0.010
 Why?
Tachycardia, Ventricular
1
2004
44
0.010
 Why?
Anti-Arrhythmia Agents
1
2004
79
0.010
 Why?
Transcription Factors
1
2007
561
0.010
 Why?
NG-Nitroarginine Methyl Ester
1
2003
18
0.010
 Why?
Cesarean Section
1
2004
187
0.010
 Why?
Swine
1
2004
393
0.010
 Why?
Endpoint Determination
1
2002
24
0.010
 Why?
Brain
1
2006
1328
0.010
 Why?
Pregnancy
1
2004
2607
0.010
 Why?
Uretsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (599) concept(s)
_
Co-Authors Expand Description
See all (9) people
_
Similar People Expand Description
See all (22) people
_
Same Department Expand Description
Search Department